Nature, Published online: 03 November 2026; doi:10.1038/d41586-026-03504-2
Physicians were excited about several therapies that slash levels of lipoprotein(a) — an important cardiovascular risk factor. One major trial failed to show a benefit, and now scientists are scrambling to work out what that means.General
This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?
Nature News0 views
Source:https://www.nature.com/articles/d41586-026-03504-2
PreviousWill AI grant reviews make science more conservative?NextDaily briefing: ‘A triumph of scientific self-correction’
Related posts
The 'Astra can read and write weights to improve Qwen' post is misleading
0Hacker News
Charles Tandy, the mastermind behind Radio Shack
0Hacker News
Has Anyone tried making a game engine? How does it even work? I'm curious.
0dev.to Discuss
The solar system that won't hold still: map for 800k bodies
0Hacker News New
Our software factory: agents write and ship code, verification replaces review
0Hacker News New
Thoughts as Thinkers: the biology and computer science of inspiration [video]
0Hacker News New